Refae, Sadal
Gal, Jocelyn
Brest, Patrick
Giacchero, Damien
Borchiellini, Delphine
Ebran, Nathalie
Peyrade, Frederic
Guigay, Joël
Milano, Gérard
Saada-Bouzid, Esma
Article History
Received: 9 August 2019
Accepted: 11 February 2020
First Online: 27 February 2020
Change Date: 12 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: Gérard Milano is a member of an advisory board at B.M.S., M.S.D. and Merck. Fréderic Peyrade is a member of an advisory board at M.S.D. and Merck. Delphine Borchiellini is a member of an advisory board at M.S.D., Pfizer, Astra-Zeneca, Roche, B.M.S. Joel Guigay is a member of an advisory board at Merck. The remaining authors declare no competing interests.